MNBTD
LGND icon

Moody National Bank Trust Division’s Ligand Pharmaceuticals LGND Stock Holding History

Moody National Bank Trust Division’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.84M Buy
+12,147
New +$2.86M 0.32% 58
2019
Q1 		– Sell
-77
Closed -$7K – 1308
2018
Q4 		$7K Buy
+77
New +$8.21K ﹤0.01% 648

Other funds holding LGND

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Moody National Bank Trust Division's LGND Position: Q2 2026 in Review

Moody National Bank Trust Division opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 12,147 shares worth $3.84M. The stake represents 0.32% of the portfolio and ranks #58 among its holdings. This is a return to the name: Moody National Bank Trust Division previously reported a position in LGND as recently as Q4 2018.

Moody National Bank Trust Division first reported a position in LGND in Q4 2018 and has held it in 2 quarters since. 179 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Moody National Bank Trust Division held 12,147 shares of Ligand Pharmaceuticals worth $3.84M as of Q2 2026.
  • Ligand Pharmaceuticals was a new Moody National Bank Trust Division position in Q2 2026.
  • Ligand Pharmaceuticals made up 0.32% of Moody National Bank Trust Division's portfolio in Q2 2026, its #58 holding.
  • Moody National Bank Trust Division first reported a position in Ligand Pharmaceuticals in Q4 2018 and has held it in 2 quarters since.
  • 179 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Moody National Bank Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.